Risk of post-gastric bypass surgery hypoglycemia in nondiabetic individuals: A single center experience

Obesity (Silver Spring). 2016 Jun;24(6):1342-8. doi: 10.1002/oby.21479.

Abstract

Objective: The epidemiology of post-gastric bypass surgery hypoglycemia (PGBH) is incompletely understood. This study aimed to evaluate the risk of PGBH among nondiabetic patients and associated factors.

Methods: A cohort study of nondiabetic patients who underwent Roux-en-Y gastric bypass (RYGB) was conducted. PGBH was defined by any postoperative record of glucose < 60 mg/dL, diagnosis of hypoglycemia, or any medication use for treatment of PGBH. Kaplan-Meier analysis was used to describe PGBH occurrence, log-rank tests, and Cox regression to examine associated factors.

Results: Of the 1,206 eligible patients, 86% were female with mean age of 43.7 years, mean preoperative BMI of 48.7 kg/m(2) , and a mean follow-up of 4.8 years. The cumulative incidence of hypoglycemia at 1 and 5 years post-RYGB was 2.7% and 13.3%, respectively. Incidence of PGBH was identified in 158 patients and was associated with lower preoperative BMI (P = 0.048), lower preoperative HbA1c (P = 0.012), and higher 6-month percent of excess body weight loss (%EWL) (P = 0.001). A lower preoperative HbA1c (HR = 1.73, P = 0.0034) and higher 6-month %EWL (HR = 1.96, P = 0.0074) remained independently correlated with increased risk for PGBH in multi-regression analysis.

Conclusions: The 5-year incidence of PGBH among nondiabetic individuals was 13.3% and was associated with a lower preoperative HbA1c and greater weight loss at 6 months following surgery.

MeSH terms

  • Adult
  • Blood Glucose / metabolism
  • Body Mass Index
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Gastric Bypass / adverse effects*
  • Glycated Hemoglobin / metabolism
  • Humans
  • Hypoglycemia / blood*
  • Hypoglycemia / epidemiology*
  • Hypoglycemia / etiology
  • Incidence
  • Male
  • Middle Aged
  • Obesity, Morbid / surgery
  • Postoperative Period
  • Proportional Hazards Models
  • Risk Factors
  • Weight Loss

Substances

  • Blood Glucose
  • Glycated Hemoglobin A